Mengge Li
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
SF3B4 stabilizes SREBF1 via 3'UTR binding to drive hepatocellular carcinoma progression.
Journal: Frontiers in oncology
Published: March 21, 2026
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients.
Journal: BMC cancer
Published: January 26, 2025
Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial.
Journal: Oncology
Published: December 03, 2024
The application of QCT in the prognostic assessment of mCRC undergoing first-line treatment based on bevacizumab.
Journal: Future oncology (London, England)
Published: November 19, 2024
Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer.
Journal: Clinical and translational medicine
Published: October 30, 2024
A machine learning model utilizing CT radiomics features and peripheral blood inflammatory markers predicts the prognosis of patients with unresectable esophageal squamous cell carcinoma undergoing PD-1 inhibitor combined with concurrent chemoradiotherapy.
Journal: Journal of Cancer
Published: October 14, 2024
HBV DNA integration gene CCDC91 is oncogenic and a potential therapeutic target for hepatocellular carcinoma.
Journal: Communications biology
Published: September 28, 2024
Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis.
Journal: Cancer medicine
Published: May 30, 2024
Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients.
Journal: BMC cancer
Published: February 27, 2024
Identification of hepatitis B virus infection and integration and its oncogenic role in gastric cancer.
Journal: Clinical and translational medicine
Published: December 21, 2023
Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens.
Journal: Journal of cancer research and clinical oncology
Published: May 04, 2023
Last Updated: 09/26/2026